Health & public health
47 recently collected links. Updated independently of the front-page selection.
- POLICY“Insurance is a game of large numbers, and we don’t have those numbers.”
- POLICYFDA revokes authorization of some chemicals used in food dye production
- POLICYDespite concerns, AI becomes daily fixture in physician workflows
- POLICYUnitedHealth audit of insurer policies ducks question of denials
- POLICYIsraeli strike on Gaza hospital deadliest since election
- POLICYSTAT+: Scientists debut map of basal ganglia, a key brain region involved in an array of diseases
- POLICYSTAT+: Will Heidi Overton get to run the FDA?
- POLICYSTAT+: New documents raise more questions about Medicare’s AI prior-authorization experiment
- POLICYSTAT+: Pharmalittle: We’re reading about FDA shelving fast-track review, a Canadian importer arrested, and more
- POLICYExperts update prostate cancer screening guidelines for men
- POLICYCDC eliminates $29 million for HIV prevention in Texas
- POLICYDubious Buys Raise Alarm Over Local Control of Opioid Cash
- POLICYOpinion: 3 things new governors must do to lead on health
- POLICYNewly elected doctors and scientists hope to restore trust in science. It won’t be easy
- AGENCIESThis Tiny Agency Carries Big Sway on Medicare Policy. Meet the Man Who Led It.
- POLICYEven With Insurance, Many Americans Can't Afford Healthcare
- POLICYNC children’s advocates push for more funding to improve student mental health
- POLICYSTAT+: Most-favored nations policy makes drugmakers rethink launches abroad
- POLICYOura makes bet on AI in healthcare with $625M Counsel Health buy
- POLICYSTAT+: Why this former ER doc thinks giving AI less information is sometimes better
- POLICYSTAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA
- POLICYThis law was supposed to force more Californians into mental health treatment. What happened?
- POLICYWith California’s insurance crisis at an impasse, it might be time for a different approach
- POLICYThe U.S. may soon lose measles elimination status
- POLICY“We Have No One”: How Trump’s Dismantling of the VA Left a Veterans Hospital in Crisis
- POLICYSTAT+: MDCalc launches a ‘rumble strip’ for doctors using generative AI tools
- POLICYOpinion: Low-income parents can’t afford to take chances with nutritious food their picky eaters might reject
- POLICYSTAT+: Doctors on Kennedy’s influential preventive care panel have major conflicts of interest, filings reveal
- POLICYA new tactic in the war over out-of-network bills: Health care providers are suing employers
- COURTSFired judge’s lawsuit alleges California was illegally approving insurance rate hikes
- POLICYSTAT+: Democrats take new step toward investigating Trump’s drug pricing deals
- POLICYSTAT+: Wyden, Sanders hand-in-hand on ‘Medicare for All’ initiative
- HILLDemocratic Congress likely to scrutinize Medicaid work requirements, Medicare AI test
- POLICYSTAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug
- POLICYSTAT+: Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
- POLICY7 healthcare experts on adopting AI tools
- POLICYFDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
- POLICYSTAT+: GLP-1s are given an FDA warning for rare eye condition risk
- POLICYSTAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
- POLICYSTAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds
- POLICYStudents Who Turn to AI for Emotional Support Report Worse Mental Health
- POLICYThe Ultimate Adulting Task: Signing Up for Health Insurance
- POLICYNebraska Rushed Medicaid Work Rules. Then a Cancer Patient Was Told He’d Lost Coverage.
- POLICYSTAT+: State Democratic wins make Medicaid expansion a possibility for more than a million people
- POLICYOpinion: AI’s health advice can be accurate and still make us sicker
- POLICYFive FAQs homeowners have about private flood insurance
- POLICYSTAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug